GSK, Human Genome in co-development project

07/8/2005 | American City Business Journals

GlaxoSmithKline plans to co-develop a rheumatoid arthritis drug being tested by Human Genome Sciences. GSK said it would exercise its co-development option under a 1996 agreement between the two firms, with both companies sharing the costs of late-stage clinical trials and marketing costs if the drug is commercialized.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI